Literature DB >> 35031840

Capability of intravoxel incoherent motion and diffusion tensor imaging to detect early kidney injury in type 2 diabetes.

Haoran Zhang1, Peng Wang2, Dafa Shi1, Xiang Yao1, Yanfei Li1, Xuedan Liu1, Yang Sun1, Jie Ding1, Siyuan Wang1, Guangsong Wang1, Ke Ren3,4.   

Abstract

OBJECTIVES: To prospectively investigate the capability of intravoxel incoherent motion (IVIM) and conventional diffusion tensor imaging (DTI) to identify early kidney function injury in type 2 diabetes.
METHODS: Forty-one diabetes patients (normoalbuminuria: n = 27; microalbuminuria: n = 14) and 28 volunteers were recruited. All participants were examined using DTI and IVIM with 3.0-T MRI. DTI parameters (mean diffusivity [MD], fractional anisotropy [FA]), and IVIM parameters (true diffusion coefficient [D], pseudo-diffusion coefficient [D*], and pseudo-diffusion component fraction [f]) were measured in the renal parenchyma (cortex and medulla) by two experienced radiologists independently. Image features were compared among the groups using separate one-way analyses of variance. Diagnostic performances of various diffusion parameters for predicting diabetic renal damage were compared.
RESULTS: The medullary D and FA values were significantly different among the microalbuminuria subgroup, normoalbuminuria subgroup, and control group (all p < 0.001). In medulla, area under the curve (AUC) values for combined FA and D were significantly higher than single FA (AUC = 0.938, 0.769, respectively; p = 0.003), and the combined AUC of FA and D was numerically higher than that of single D (0.938 vs 0.878, p > 0.05). AUC of combined FA and D was 0.985, not significantly different from individual AUC for FA and D (AUC = 0.909 and 0.952, respectively; all p > 0.05) in differentiating the microalbuminuria subgroup from the control group.
CONCLUSION: IVIM-derived D and DTI-derived FA values were better than other parameters for evaluating early kidney impairment of diabetes. The single indicator FA and D performed as well as the combined diagnostic indicator in the medulla for differentiating the microalbuminuria subgroup from the control group. KEY POINTS: • We speculated that early renal progression in type 2 diabetes result from restricted tubular flow and kidney tubule dysregulation may precede or at least accompany abnormal glomerular changes. • In medulla, the AUC values of FA and D and the combination of FA and D obtained by comparing the microalbuminuria subgroup with the control group were 0.909, 0.952, and 0.985, respectively. • IVIM-derived D and DTI-derived FA are effective MR biomarkers to evaluate early alterations of the renal function in patients with diabetes.
© 2021. The Author(s), under exclusive licence to European Society of Radiology.

Entities:  

Keywords:  Diabetes; Diabetic kidney disease; Diffusion tensor imaging; Intravoxel incoherent motion

Mesh:

Year:  2022        PMID: 35031840     DOI: 10.1007/s00330-021-08415-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  49 in total

Review 1.  Biomarkers of diabetic nephropathy: A 2017 update.

Authors:  Nektaria Papadopoulou-Marketou; Christina Kanaka-Gantenbein; Nikolaos Marketos; George P Chrousos; Ioannis Papassotiriou
Journal:  Crit Rev Clin Lab Sci       Date:  2017-09-28       Impact factor: 6.250

Review 2.  Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

Review 3.  Diagnosis and Management of Type 2 Diabetic Kidney Disease.

Authors:  Simit M Doshi; Allon N Friedman
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-09       Impact factor: 8.237

4.  Potential biomarkers for early detection of diabetic kidney disease.

Authors:  Salman Hussain; Anwar Habib; Md Sarfaraj Hussain; Abul Kalam Najmi
Journal:  Diabetes Res Clin Pract       Date:  2020-02-11       Impact factor: 5.602

Review 5.  Worldwide access to treatment for end-stage kidney disease: a systematic review.

Authors:  Thaminda Liyanage; Toshiharu Ninomiya; Vivekanand Jha; Bruce Neal; Halle Marie Patrice; Ikechi Okpechi; Ming-hui Zhao; Jicheng Lv; Amit X Garg; John Knight; Anthony Rodgers; Martin Gallagher; Sradha Kotwal; Alan Cass; Vlado Perkovic
Journal:  Lancet       Date:  2015-03-13       Impact factor: 79.321

Review 6.  Update of pathophysiology and management of diabetic kidney disease.

Authors:  Yi-Chih Lin; Yu-Hsing Chang; Shao-Yu Yang; Kwan-Dun Wu; Tzong-Shinn Chu
Journal:  J Formos Med Assoc       Date:  2018-03-02       Impact factor: 3.282

7.  Diffusion-weighted magnetic resonance imaging to assess diffuse renal pathology: a systematic review and statement paper.

Authors:  Anna Caroli; Moritz Schneider; Iris Friedli; Alexandra Ljimani; Sophie De Seigneux; Peter Boor; Latha Gullapudi; Isma Kazmi; Iosif A Mendichovszky; Mike Notohamiprodjo; Nicholas M Selby; Harriet C Thoeny; Nicolas Grenier; Jean-Paul Vallée
Journal:  Nephrol Dial Transplant       Date:  2018-09-01       Impact factor: 5.992

Review 8.  Biomarkers of diabetic kidney disease.

Authors:  Helen M Colhoun; M Loredana Marcovecchio
Journal:  Diabetologia       Date:  2018-03-08       Impact factor: 10.122

Review 9.  Diabetic kidney diseases revisited: A new perspective for a new era.

Authors:  Haiyan Fu; Silvia Liu; Sheldon I Bastacky; Xiaojie Wang; Xiao-Jun Tian; Dong Zhou
Journal:  Mol Metab       Date:  2019-10-17       Impact factor: 7.422

Review 10.  Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis.

Authors:  Caroline S Fox; Kunihiro Matsushita; Mark Woodward; Henk J G Bilo; John Chalmers; Hiddo J Lambers Heerspink; Brian J Lee; Robert M Perkins; Peter Rossing; Toshimi Sairenchi; Marcello Tonelli; Joseph A Vassalotti; Kazumasa Yamagishi; Josef Coresh; Paul E de Jong; Chi-Pang Wen; Robert G Nelson
Journal:  Lancet       Date:  2012-09-24       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.